Novel C-6 fluorinated acyclic side chain pyrimidine derivatives: synthesis, (1)H and (13)C NMR conformational studies, and antiviral and cytostatic evaluations. 2007

Svjetlana Prekupec, and Damjan Makuc, and Janez Plavec, and Lidija Suman, and Marijeta Kralj, and Kresimir Pavelić, and Jan Balzarini, and Erik De Clercq, and Mladen Mintas, and Silvana Raić-Malić
Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Marulićev trg 20, P.O. Box 177, HR-10000 Zagreb, Croatia.

The synthetic route for introduction of a fluoroalkyl (7-12, 14), fluoroalkenyl (15 and 16), fluorophenylalkyl (17, 19, 20, and 22), and fluorophenylalkenyl (18, 21) side chain at C-6 of the pyrimidine involved the lithiation of the pyrimidine derivatives 3 and 3a and subsequent nucleophilic addition or substitution reactions of the organolithium intermediate thus obtained with various electrophiles. Conformational properties of the novel fluorinated pyrimidine derivatives were assessed by the use of 1D difference NOE enhancements and C-F coupling constants. Compounds 4-22 were evaluated for their antiviral and cytostatic activities. Of all compounds evaluated, the 5-bromopyrimidine derivatives 5 and 6 showed the highest inhibitory activities. Among the series of fluoroalkylated pyrimidines, which is generally more active than the series of fluorophenylalkylated pyrimidines, compounds 8 and 14 displayed moderate cytostatic activities against the tested tumor cell lines. Moreover, compound 8 containing a 2-fluoromethylpropyl side chain expressed some but not highly specific activity against varicella-zoster virus (VZV). From C-6 fluorophenylalkylated pyrimidine derivatives, 17a and 21 showed a slight activity against cytomegalovirus (CMV), VZV, and Coxsackie B4 virus, respectively. Besides, compounds 17a and 21 showed no cytotoxic effect.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Svjetlana Prekupec, and Damjan Makuc, and Janez Plavec, and Lidija Suman, and Marijeta Kralj, and Kresimir Pavelić, and Jan Balzarini, and Erik De Clercq, and Mladen Mintas, and Silvana Raić-Malić
June 2008, Chemical biology & drug design,
Svjetlana Prekupec, and Damjan Makuc, and Janez Plavec, and Lidija Suman, and Marijeta Kralj, and Kresimir Pavelić, and Jan Balzarini, and Erik De Clercq, and Mladen Mintas, and Silvana Raić-Malić
January 2016, Magnetic resonance in chemistry : MRC,
Svjetlana Prekupec, and Damjan Makuc, and Janez Plavec, and Lidija Suman, and Marijeta Kralj, and Kresimir Pavelić, and Jan Balzarini, and Erik De Clercq, and Mladen Mintas, and Silvana Raić-Malić
November 2009, Molecules (Basel, Switzerland),
Svjetlana Prekupec, and Damjan Makuc, and Janez Plavec, and Lidija Suman, and Marijeta Kralj, and Kresimir Pavelić, and Jan Balzarini, and Erik De Clercq, and Mladen Mintas, and Silvana Raić-Malić
January 2008, Nucleic acids symposium series (2004),
Svjetlana Prekupec, and Damjan Makuc, and Janez Plavec, and Lidija Suman, and Marijeta Kralj, and Kresimir Pavelić, and Jan Balzarini, and Erik De Clercq, and Mladen Mintas, and Silvana Raić-Malić
July 2011, Antiviral chemistry & chemotherapy,
Svjetlana Prekupec, and Damjan Makuc, and Janez Plavec, and Lidija Suman, and Marijeta Kralj, and Kresimir Pavelić, and Jan Balzarini, and Erik De Clercq, and Mladen Mintas, and Silvana Raić-Malić
May 2008, Bioorganic & medicinal chemistry,
Svjetlana Prekupec, and Damjan Makuc, and Janez Plavec, and Lidija Suman, and Marijeta Kralj, and Kresimir Pavelić, and Jan Balzarini, and Erik De Clercq, and Mladen Mintas, and Silvana Raić-Malić
January 2012, Bioorganic & medicinal chemistry letters,
Svjetlana Prekupec, and Damjan Makuc, and Janez Plavec, and Lidija Suman, and Marijeta Kralj, and Kresimir Pavelić, and Jan Balzarini, and Erik De Clercq, and Mladen Mintas, and Silvana Raić-Malić
July 2011, Molecules (Basel, Switzerland),
Svjetlana Prekupec, and Damjan Makuc, and Janez Plavec, and Lidija Suman, and Marijeta Kralj, and Kresimir Pavelić, and Jan Balzarini, and Erik De Clercq, and Mladen Mintas, and Silvana Raić-Malić
September 2012, Magnetic resonance in chemistry : MRC,
Svjetlana Prekupec, and Damjan Makuc, and Janez Plavec, and Lidija Suman, and Marijeta Kralj, and Kresimir Pavelić, and Jan Balzarini, and Erik De Clercq, and Mladen Mintas, and Silvana Raić-Malić
January 2009, European journal of medicinal chemistry,
Copied contents to your clipboard!